ORKA Sale Disclosure
Klein Lawrence Otto · SEC Form 4 · Filed Nov 2, 2026
Sale
Calculated transaction value
$612.79K
Klein Lawrence Otto Chief Executive Officer
ORKA
Oruka Therapeutics
ORKA
Transaction date
Nov 2, 2026
Public filing date
Nov 2, 2026
Filing lag
Filed same day
ORKA daily price context
Close on/before transaction
$95.43
Nov 2, 2026
First close after public filing
$99.55
Nov 3, 2026
Return after filing · so far
+3.32%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 6,466 shares @ $94.77
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0000907654-26-000112
Filing cohort
Transactions in this filing
Showing 7 of 7
Trades
7
Issuers
1
Estimated value
$2.59M
Buys / sales
0 / 5
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Oruka Therapeutics, Inc. ORKA | Sale | Nov 2, 2026 | $236.15K |
| Oruka Therapeutics, Inc. ORKA | Sale | Nov 2, 2026 | $29.52K |
| Oruka Therapeutics, Inc. ORKA | Exercise | Nov 2, 2026 | $195K |
| Oruka Therapeutics, Inc. ORKA | Sale | Nov 2, 2026 | $1.44M |
| Oruka Therapeutics, Inc. ORKA | Exercise | Nov 2, 2026 | $0 |
| Oruka Therapeutics, Inc. ORKA Current | Sale | Nov 2, 2026 | $612.79K |
| Oruka Therapeutics, Inc. ORKA | Sale | Nov 2, 2026 | $73.68K |